(Adds company news items, futures)
July 15 (Reuters) - Britain's futures .FFIc1 is seen opening up 0.01% on
Monday, with futures FFIc1 up 0.02% ahead of the cash market open.
* SPORTS DIRECT: Sports Direct SPD.L said on Monday it had delayed the
publication of its preliminary results due to problems integrating House of
Fraser and increased scrutiny of its accounts which could affect its guidance.
* GLAXOSMITHKLINE: GlaxoSmithKline GSK.L said on Monday a late-stage study
testing Zejula as a maintenance therapy in patients with first-line ovarian
cancer showed positive headline results.
* ASTRAZENECA: British drugmaker AstraZeneca Plc AZN.L said on Monday the
U.S. Food and Drug Administration declined to approve its diabetes treatment,
Farxiga, for use as a supplement to insulin in adults with Type-1 diabetes.
* YELLOW CAKE: Uranium fund Yellow Cake YCA.L on Monday cheered U.S.
President Donald Trump's decision to not implement fresh trade restrictions on
U.S. uranium imports and said it expects activity in the market to pick up in
the near term.
* INDIVIOR: A divided federal appeals court on Friday ruled against Indivior
Plc INDV.L in its bid to stop Dr. Reddy's Laboratories Ltd REDN.NS , RDY.N
and Alvogen from selling generic versions of its opioid addiction treatment
Suboxone film that infringed its patents. * KCOM: Macquarie unit MEIF 6 Fibre Ltd is to buy KCOM Group Plc KCOM.L in
a deal that values the British telecoms company at 627 million pounds ($787.5
million), ending a bidding war with a UK pension fund. * GLAXOSMITHKLINE: Glaxosmithkline Plc GSK.L is in talks to name HSBC's
deputy chairman Jonathan Symonds as the next chairman of the British drugmaker,
Bloomberg reported on Sunday, citing a person familiar with the matter.
* GOLD: Gold prices slipped on Monday, consolidating above $1,400 pivot, as
key China data assuaged concerns about global economic slowdown and boosted
appetite for riskier assets. * OIL: Oil prices slipped on Monday after China posted its slowest quarterly
economic growth in at least 27 years, reinforcing concerns about demand in the
world's largest crude oil importer. * The UK blue chip index closed 0.1% lower on Friday, led lower by losses in
pharmaceuticals after the U.S. White House scrapped a rebate rule, while the
midcap bourse jumped on prospects of lower interest rates. * For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB